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Abstract—Bioﬂuid mechanics is increasingly applied in
support of diagnosis and decision-making for treatment of
clinical pathologies. Exploring the relationship between
blood ﬂow phenomena and pathophysiological observations
is enhanced by continuing advances in the imaging modal-
ities, measurement techniques, and capabilities of computa-
tional models. When combined with underlying physiological
models, a powerful set of tools becomes available to address
unmet clinical needs, predominantly in the direction of
enhanced diagnosis, as well as assessment and prediction of
treatment outcomes. This position paper presents an over-
view of current approaches and future developments along
this theme that were discussed at the 5th International
Bioﬂuid Symposium and Workshop held at the California
Institute of Technology in 2008. The introduction of novel
mechanical biomarkers in device design and optimization,
and applications in the characterization of more speciﬁc and
focal conditions such as aneurysms, are at the center of
attention. Further advances in integrative modeling, incor-
porating multiscale and multiphysics techniques are also
discussed.
Keywords—Cardiovascular ﬂuid mechanics, Hemodynamics,
Imaging, Computational modeling, Physiological modeling.
ABBREVIATIONS
FSI Fluid–structure interaction
3D Three-dimensional
PC-MRI Phase-contrast magnetic resonance
imaging
HFI Helical ﬂow index
WIA Wave intensity analysis
INTRODUCTION
Transport phenomena in general and biological
ﬂuid mechanics in particular play an important role in
better understanding of clinical and pathological
observations and in developing new methods for
diagnosis in connection with physiological and/or
computational models. Although bioﬂuid concepts
apply to numerous systems in the human body,
including the ocular,
28 lymphatic,
48 synovial,
79 cere-
brospinal,
43 cochlear,
58 pulmonary,
5 nasal,
24,80 and
others,
64 the focus in this exposition is on the cardio-
vascular system. Because of its physiological predom-
inance and clinical importance, arterial cardiovascular
ﬂuid dynamics has become the mainstay of transport
phenomena biomechanics.
The topic of this position paper deals with correla-
tion of clinical observations with the biomechanics of
blood ﬂow; in other words, we explore the link between
observations of hemodynamic phenomena and mech-
anisms that have a strong mechanical component in
their causal chain with disease manifestations or
pathophysiological indicators. Apart from the funda-
mental interest in such correlations, there is strong
practical beneﬁt, since investigation of directly acces-
sible or computed bioﬂuidic observables cannot only
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1216lead to improved diagnostic capabilities but also to
assessment and even prediction of treatment out-
comes.
47 Progress in imaging and measurement tech-
nology (in vivo or in silico) has dramatically increased
our access to such observables in recent years.
We can exemplify the topic of this theme using an
early case that is considered a classic nowadays: a
correlation was proposed almost 40 years ago between
atherosclerosis, considered the most prevalent vascular
disease, and patterns of abnormal wall shear stress.
12
This study, along with a multitude of subsequent
works based on this premise, apart from shedding light
on a complicated and multifactorial condition, also
implies that if we can identify regions of abnormal wall
shear stress (a purely mechanical measure) then we can
predict where atherosclerosis may emerge (other fac-
tors contributing to the disease notwithstanding). Al-
though this example relates speciﬁcally to the
interaction of mechanical forces with the endothelium,
which has evolved into a highly active research area in
its own right,
18,23 it serves to clarify the central theme
of this paper: by establishing links of bioﬂuid observ-
ables (pressure, ﬂow, wall shear stress, etc.) to clinical
pathological or functional observables (vascular dis-
ease, organ perfusion, cardiac performance, etc.), we
utilize the former as a predictor-precursor of the latter.
Especially for early stages of disease, it is hoped that
such mechanical biomarkers may serve as early risk
assessment for conditions that have some bioﬂuidic
component.
31 Observations of this nature have trig-
gered a host of similar assertions, and efforts to build
more integrative and comprehensive models evolving
around such bioﬂuid foundations are now taking
place. These links also provide important and much
needed tools to support clinical decision-making in
diagnosis, assessment of therapeutic interventions, and
optimization of cardiovascular devices.
61
To summarize, this theme explores the congruence
of cardiovascular pathophysiology and the techniques
and know-how to measure, or to compute, related
biophysical parameters. By bringing those two tracks
closer together, we envisage developing better diag-
nostic and prognostic tools for the cardiovascular
system, where the hemodynamic component is given
due importance, both as a contributing mechanism but
also as a predictor of physiological behavior.
In the following sections, we shall give a brief out-
line of recent progress, as reported at this symposium.
Any such exposition, given the vibrancy and produc-
tivity of the ﬁeld, cannot be complete or even ade-
quate, and we aim not at such coverage. We close with
an outlook on future developments and recommen-
dation of priority objectives for the integration of
bioﬂuid-physiological modeling in healthcare applica-
tions.
BIOFLUID MODELING IN STUDYING
CARDIOVASCULAR DEVICES
The correlation of bioﬂuid with clinical observa-
tions ﬁnds direct and promising application in the case
of devices, especially implantable devices. As reported
also elsewhere in this issue, a very substantial eﬀort is
being made to marry vasculature and implants in
imaging and computational ﬂuid dynamics to derive
indicators for the eﬃcacy, safety, and performance of
heart valves, stents, coils, or grafts.
Major advances have been reported recently toward
developing predictive ﬂuid–structure interaction (FSI)
algorithms that can simulate prosthetic heart valve
hemodynamics at physiologic conditions and at reso-
lution suﬃciently ﬁne to probe the links between
hemodynamics and blood-cell damage.
32,33,65 While
heart valve studies (natural and artiﬁcial) focused
mostly on the blood hemodynamics of the problem up
until the recent past, an emerging trend is observed for
additional mechanisms like thrombosis, hemolysis,
calciﬁcations etc., to be included in such simulations.
25
This type of multiphysics-enhanced modeling is not
conﬁned to the implants ﬁeld, as we shall see in the
sequel. Experimental measurements of vorticity
dynamics downstream of a bileaﬂet mechanical valve
in a straight axissymmetric vessel have been repro-
duced in such numerical simulations with very good
ﬁdelity.
20 The simulations also provided the ﬁrst
glimpse into the complex, 3D hemodynamic environ-
ment experienced by blood cells especially during the
decelerating ﬂow phase when the ﬂow transitions to
turbulence and resolved a number of subtle features of
experimentally observed valve kinematics, such as the
asymmetric opening and closing of the leaﬂets and
the leaﬂet rebound during closing.
9 Results of high-
resolution FSI simulations of a mechanical bileaﬂet
valve in a curved, anatomic aorta have shown the
important role the aortic geometry plays on both the
ﬂow patterns and the leaﬂet kinematics.
8,10 Computa-
tional ﬂuid dynamics was also used to investigate the
hemodynamics through a transcatheter aortic valve at
different stages of sclerotic degeneration.
26 The unique
geometry of these stented bioprosthetic valves resulted
in a large increase in peak wall shear stress on the
leaﬂets with advanced degeneration. The orientation of
the leaﬂets with respect to the aortic root sinus at the
time of implantation may play an important role in
optimizing leaﬂet kinematics and the durability of
these percutaneous implants. Integrative modeling of
heart valves has also been used to elucidate the
thrombogenicity of speciﬁc devices due to shear stress-
triggered platelet activation.
25
It is generally accepted that in silico or in vitro
optimization of devices is only the ﬁrst step in the
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followed by studies that attempt to examine the per-
formance of devices implanted (in reality or virtually)
in anatomically accurate vascular segments. Those
devices are usually stents, grafts or coils (the latter used
mostly for the embolization of cerebral aneurysms).
Detailed discretization of several open stents for cere-
bral aneurysms yielded clear trends for the preferred
device, at least for the particular aneurysm tested.
60
For the same pathology, an attempt to utilize a mul-
tiscale approach based on porous media considerations
was reported, aiming at computing the ﬂow reduction
caused by the implantation of detachable platinum
coils.
39 In this case also, the results obtained conﬁrm
clinical experience and practice. Similarly, the effects of
theoretical stent implantation in a coronary artery
were investigated recently.
44 Relatively few reports are
available for devices connected to the venous system;
other examples relate to hemodialysis grafts
75 or
arteriovenous ﬁstulae.
41
The introduction of computational techniques that
are more inherently capable in handling the complex-
ities of blood ﬂow and its biological and biomechanical
interactions should be mentioned here. An example of
this type of approach is the lattice Boltzmann method,
which has been used for the modeling of thrombosis
37
or for the multiscale modeling of the particulate nature
of blood and related ﬂow phenomena.
2,3,16,19,45,62
Research eﬀorts such as those described above
provide good correlation of simulation results with
experimental and clinical data and can therefore help
in the design of better devices.
BIOFLUID MODELING APPLICATIONS
IN 3D CURVED VESSELS
The onset of complex hemodynamics
50 is initiated
by the curved, three-dimensional form of the aortic
arch and coronary vessels. In particular, the ascending,
transverse, and descending aorta, joined with the
structures projecting into the ﬂowing blood stream at
or above the aortic valve, and the ventricular twisting
and torsion during contraction
42 contribute to produce
a ﬂow ﬁeld characterized by helical motion in the
human aorta.
63
The intrinsic capability of Phase-Contrast Magnetic
Resonance Imaging (PC-MRI) to map time-accurate
three-dimensional ﬂow patterns oﬀers the possibility of
analyzing local vascular hemodynamics.
81 Novel
approaches apply topological tools and concepts of
ﬂuid mechanics (frequently used as post-processing
techniques to computational results) to MR-derived
velocimetry in the aorta.
34,52 Such techniques contrib-
ute to produce a ﬂow ﬁeld characterization that allows
for the quantitative ranking of transient blood ﬂow,
thereby enhancing our knowledge on the potential
advantages to the primary circulation arising from
asymmetries and chiralism, both in the anatomy and
hemodynamics.
In brief, particle traces are calculated from tempo-
rally resolved velocity data and an integrated
Lagrangian-based metric, the Helical Flow Index
(HFI), is derived.
51 HFI is a seven-dimensional
(velocity components, velocity gradients and time) in-
dex for helical ﬂow quantiﬁcation. The strength of HFI
is in the fact that it represents a method for ranking the
ﬂuid dynamical behavior into vessels: while it is pos-
sible to visually differentiate two and three-dimen-
sional, streamlined and vertical, ﬂow patterns during
the cardiac cycle, or between physiological and path-
ological cases, an indicator or a metric like HFI eases
the level of comparison. Initial results demonstrate
that the evolving helical ﬂow structures work in order
to mitigate loss of organization in the ﬂow ﬁeld and, as
a consequence, transition to turbulence. This suggests
the possibility that helicity formation might be the
consequence of an evolutionary optimization in natu-
rally occurring ﬂuid transport processes in the car-
diovascular system, aiming at obtaining efﬁcient
perfusion by minimizing energy dissipation and limit-
ing atherogenic ﬂow instabilities. In fact, many prop-
erties of systems presenting helicity are related to the
reduction of non-linear processes responsible for the
transfer and redistribution of energy through various
scales.
51,73
We expect that the use of hemodynamic synthetic
descriptors as a metric for ranking the behavior of
transient hemodynamics in these regions of interest
will take the utility of PC-MRI techniques to a new
level. Such advanced biomechanical topological bio-
markers, along with methods for data handling and
ﬂow feature visualization, allow for analyzing large
three-dimensional in vivo data sets and may provide
useful information in diagnosis/prognosis in clinical
practice.
BIOFLUID APPLICATIONS IN RISK
ASSESSMENT OF CEREBRAL ANEURYSMS
The bioﬂuid study of cerebral aneurysms deserves
special mention, because of the great interest this
particular pathology raises. The reasons for this in-
clude the very focal nature of the disease, that makes it
amenable to biomechanical investigation, but also the
fact that cerebral aneurysms highlight the importance
of patient-speciﬁc disease evaluation in the formula-
tion of healthcare policy: aneurysms are found in
2–5% of the general population, with very high mortality
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of these aneurysms remain asymptomatic; however,
annual incident rates of subarachnoid hemorrhage are
low, 2–40 per 100,000 subjects.
38 In spite of this
apparent lack of clinically signiﬁcant indicators, rela-
tively recent developments in imaging have led to new
healthcare policies in terms of application of medical
imaging modalities: in practice, nowadays many
admissions that involve any head-related symptom
include MR, CT, or other scanning. This trend has led
to a dramatic increase in coincidentally detected
asymptomatic cerebral aneurysms and thus to signiﬁ-
cant pressure in terms of decision-making and inter-
vention optimization.
78 In effect, there is great need for
answering the question: ‘‘once an asymptomatic lesion
is detected, should we intervene?’’, based on robust
decision-making know-how. Imaging and computa-
tional modeling as a suite can help offer answers to
these questions, by introducing quantitative risk eval-
uation criteria.
14
As mentioned before, a clear trend to examine and
characterize bioﬂuid behavior based exclusively on
rigorously extracted geometric features is emerging.
This class of techniques oﬀers the beneﬁt of very rapid
evaluation for a large population of cases. For the case
of cerebral aneurysms, the extraction of geometric
indicators, looking at connecting those with ﬂow and
pathologies, has been reported.
49 Techniques of this
nature are now culminating into large-scale studies
that hold great promise of a robust and predictive
categorization of lesions, without the need for costly
computational hemodynamics simulations, for aneu-
rysms but also for a more general assessment of cere-
bral vasculature pathologies.
46
INTEGRATION OF BIOFLUID WITH
PHYSIOLOGICAL MODELS
Although the greatest utility in establishing direct
correlations between biological ﬂuid mechanics and
observed pathophysiology is the predictive power that
such correlations oﬀer, it is becoming apparent that
in many cases the biomechanics of ﬂuid ﬂow alone,
although important, cannot be used to convey a
comprehensive and thus prognostic picture of a par-
ticular situation. To remedy this, combinations of
bioﬂuid models with models of pertinent mechanical,
biological, or physiological mechanisms are intro-
duced. Although ﬂuid–structure interaction frame-
works incorporating vascular wall mechanics and
hemodynamics have existed for some time,
29 this
theme is seeing substantial cross-disciplinary enrich-
ment through vascular biology models of wall
remodeling in risk assessment for both aneurysms
(abdominal
76 and cerebral
14,15,21,77) and coronary
plaque rupture.
40,53,55,56,59
Useful mechanistic insight can also be gained from
direct hemodynamic measurements in combination
with physiological modeling. Microvascular dysfunc-
tion plays an important role in the pathogenesis of
myocardial ischemia but is diﬃcult to assess in the
catheterization laboratory. Coronary blood ﬂow is
highly dependent on cardiac–coronary interaction and
typical ‘‘out-of-phase’’ pressure and ﬂow waveforms
result from the combined action of dynamic changes in
aortic pressure and the compression/relaxation exerted
by the beating heart on the intramural coronary vessels
that penetrate the heart muscle.
66 Coronary hemody-
namic waveforms are furthermore strongly inﬂuenced
by the presence of atherosclerotic stenoses and the
vasodilatory status of the coronary microcirculation.
However, clinical assessment of coronary artery dis-
ease and microvascular function is traditionally limited
to the analysis of beat-averaged hemodynamic data
67
and the information contained in pulsatile character-
istics of coronary ﬂow velocity and pressure is still not
well utilized. Wave intensity analysis (WIA) is a
promising time-domain method that interprets incre-
mental changes in pressure and velocity signals as the
local sum of energies carried by incident forward and
backward traveling waves.
57 This method has great
potential of developing into a powerful tool for
assessment of the human coronary microcirculation, as
it distinguishes between forward waves generated by
the variations in aortic pressure and backward waves
arising from the microcirculation due to the mechani-
cal actions of the cardiac muscle.
7 WIA has been suc-
cessfully used to elucidate waveform generation in the
epicardial coronary vessels of humans
22,36 and was
shown to provide quantitative and detailed informa-
tion for diverse cardiovascular pathologies in the sys-
temic circulation, based on noninvasive measurements
in the clinical setting.
71 Combining physiological
modeling and clinically accessible hemodynamic mea-
surements can play a key role not only in diagnosis and
treatment evaluation, but also in the validation of
image-based computational models.
CAVEATS REGARDING MEDICAL
IMAGE-BASED CFD MODELS
The proliferation and availability of imaging
modalities and computational techniques is bringing
drastic change in clinical practice. Biomechanical
indicators, when blood ﬂow is concerned, are derived
predominantly through a combination of imaging and
computer modeling. Computational simulation models
based on anatomically derived vascular geometries are
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enhanced clinical relevance nowadays.
17,68,69 This has
interesting implications in the sense that computa-
tional simulation is perceived more as a meta-modality,
i.e., a post-processing value-adding ﬁlter to clinical
imaging rather than a knowledge generator in its own
right, although the latter does indeed offer great in-
sight in complex bioﬂuidic phenomena.
6 However, in
spite of the direct clinical appeal that such anatomi-
cally accurate (or more correctly, anatomically
derived) patient-speciﬁc models present us with, they
are not without their own inherent caveats, as studies
looking at reproducibility
74 and modeling choices,
13
reveal.
Noninvasive techniques such as ultrasound and
magnetic resonance imaging are routinely used to
provide us with a wide and versatile array of parame-
ters. When referring to modeling, however, the rele-
vance and direct comparison of simulation results with
clinical observations should not be taken for granted in
all cases. While much progress has been made with
rigid wall models, the same is not true for anatomic
cases at physiological conditions. CFD codes for car-
rying out high-resolution simulations in patient-
speciﬁc geometries with compliant boundaries and at a
resolution suﬃciently ﬁne to couple hemodynamics
with biology or cellular biophysics either do not exist
or are at early developmental stages. For example, FSI
methods for simulating mechanical valves in anatomic
conﬁgurations with compliant aorta and realistic
boundary conditions from a left ventricle model are
just now beginning to emerge. The same cautionary
note holds for vascular structures and anomalies such
as aneurysms, especially in the brain, where vessels are
embedded close to surrounding soft and hard struc-
tures. The setting up of a computational model is
inevitably connected with simpliﬁcations and depar-
tures from the full system under investigation, which
sometimes implies that either the obtained results are
qualitative and should be viewed as trends only, or that
they reﬂect a selection of the pertinent physical and
biological mechanisms and, again, should be viewed in
this light.
We shall close this section by discussing brieﬂy the
issue of validation, an indispensable component of any
computational simulation model. We observe that al-
though in ﬂuid mechanics (and consequently, in bio-
ﬂuids) validation and comparison with experiments are
often straight-forward to instigate, such studies are not
as commonplace as one would expect. A natural ﬁrst
step is of course the comparison with in vitro studies,
frequently based on image-derived, anatomically
accurate topologies,
11 and ideally followed by com-
parisons with in vivo acquisitions.
72 However, unless
one is willing to accept commercial codes without
much concern about the accuracy or physiologic rele-
vance of the resulting ﬂow ﬁelds, major emphasis
should still be placed on developing and validating
ﬂow simulation tools that can predict the mechanical
environment with the appropriate level of realism. In
light of the recent trends towards multiscale/multi-
physics models, validation becomes a signiﬁcantly
more involved issue; the complexity of the models
implies that either individual components must be
validated individually (useful in early stages but less so
when the interactions between physical mechanisms
and scales are studied) or that an appropriate ‘‘reduced
system’’, where control can be exercised, is needed.
Sometimes such a system may be an animal model,
however in more cases than not, reduced systems are
very difﬁcult to devise and the only veriﬁcation of the
accuracy and predictive capability of the models is the
comparison with the ‘‘full system’’, i.e., the patient and
the speciﬁc pathology.
FUTURE DIRECTIONS: TOWARDS
INTEGRATIVE MULTI-SCALE
AND MULTI-PHYSICS MODELS
The application of sophisticated computational
simulation models for the evaluation of the progress of
disease, for the determination of long-term risk and for
the planning of optimal treatment strategies is gaining
ground in clinical practice: Personalized healthcare is a
paradigm allowing for the enhancement of treatment
speciﬁcity and eﬃcacy. At the same time, continued
progress in imaging helps reveal mechanisms and
provides diagnostic possibilities that have not been
available before.
The need for comprehensive, integrative models is
gaining recognition. The terms ‘‘multiscale’’ and
‘‘multiphysics’’ are adequately descriptive of the
direction this eﬀort is taking.
1,35 Many clinically rele-
vant problems in cardiovascular biomedical engineer-
ing involve either spatially/temporally diverse scales or
multiple mechanisms at intricate interplay with each
other, or a combination of both. Examples like the
following point up their prevalence in cardiovascular
biomechanics: multi-bifurcation simulations, coupling
of electrophysiology and perfusion with hemodynam-
ics, the biochemistry of thrombosis, ﬂow in micro-
scopic regions of mechanical valves such as the valve
hinges and the leakage jet during closure, wall
remodeling, signaling pathways, and histology. They
also underscore the importance that such complex
mechanisms play in health and disease.
Although the majority of reported works in cardio-
vascular modeling involve the vasculature, there is
evidence that more attention is being drawn to the heart
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the combination of coronary hemodynamics with the
contractile motion of the myocardium, as triggered by
the heart electrophysiology, is being reinforced as an
important component of cardiovascular research and
shows that the cardiac system is amenable to detailed
modeling.
54 Such multifaceted models, apart from the
vast theoretical interest they present, can also serve as
test beds for medication candidates and surgical treat-
ments. Prominent examples of current research pursuits
under this paradigm are the Cardiac Physiome
4 and the
Virtual Physiological Human (VPH) initiative
70 that
brings together several EU funded ICT-based projects
for modeling and simulation of human physiology,
such as the FP6 ‘‘@neurIST’’ project
30 (http://www.
aneurist.org) and the recently started FP7 ‘‘euHeart’’
project
27 (http://www.euHeart.eu).
The inherent abundance of information provided by
most integrative modeling approaches makes straining
through simulation outcomes in search of clinically
relevant indicators a formidable task in its own right.
To put it diﬀerently, the translation of computational
results to clinical conclusions involves a reductionist
operation that at present is neither formalized nor of a
globally acceptable nature. Scientiﬁc visualization of
course plays a role in this eﬀort, but more often than
not, it is basic integral indicators that better convey the
message and are needed.
The personalization of healthcare, a prevalent topic
in the projections of experts on the developments ex-
pected in the near and mid-term future, constitutes an
umbrella idea that covers many practical applications.
An area where we expect to see imminent translation
of computational techniques to clinical practice is the
pre-interventional evaluation of the eﬀectiveness of
implants, involving comparing potential devices and
selecting the best for the particular patient/lesion. With
adequate progress, these integrated models can also
represent a powerful tool for the computer-assisted
surgery. Despite the promising outlook of patient-
speciﬁc modeling in future healthcare applications,
emphasis still needs to be placed on producing ade-
quately validated predictive computational tools if the
goal is to make a real impact on medical practice.
CHALLENGES IN EMERGING HEALTHCARE
APPLICATIONS
The study of blood ﬂow using computational tech-
niques is developing at an accelerated pace. As we have
discussed above, there are numerous studies entailing
detailed comparisons and correlations of computed
results with clinical observables; computations help
elucidate underlying physiological or biophysical
mechanisms, and, conversely, clinical observations
guide and inspire the development of new models.
Anatomically derived models of vasculature show
great promise to deliver new levels of insight. However,
progress is hindered in exactly those areas where the
strength of such an approach would be expected. For
example, we mentioned that there is a clear trend to
make simulations a lot more multifactorial, multiscale,
and multiphysics, and to include all the relevant
mechanisms at play. In vascular bioﬂuids, this inevi-
tably means ﬁrst incorporating the interaction of vas-
cular wall dynamics, and vascular wall remodeling at a
later stage. Although such approaches have already
yielded valuable information on the basic processes at
play when formulated around idealized vasculature
models, developing them further to anatomically
derived models leads to a direct and exigent need for
additional subject-speciﬁc parameters. An often used
example, pertinent to coupled blood-artery simula-
tions, involves the need to provide information on
vascular wall thickness, wall composition, and the
perivascular environment. The latter, often over-
looked, seems to be a critical factor in the distribution
of loads on (at least certain segments of) vasculature.
In any case, all three additional pieces of information,
in more cases than not, are diﬃcult to acquire. For
certain large vessels, thickness is available non-inva-
sively, but wall composition and, more importantly,
mechanical properties of wall constituents are diﬃcult
to extract. In this combined imaging-modeling track of
anatomically derived simulations, gaining access to
such speciﬁcity is emerging as an important part of the
big picture.
Although there has been very signiﬁcant progress in
the processing chains that are used in establishing
anatomically accurate hemodynamics computations,
the desired level of integration and automation is still
missing. A key challenge for the near future is to
establish a reliable, eﬃcient, push-of-a-button tool for
in vivo detailed blood ﬂow quantiﬁcation in clinical
practice. The existence of such a suite constitutes an
inexorable demand of the medical community, if
computational models are to be adopted in a health-
care environment. These pursuits have to go hand-in-
hand with the development of advanced methods for
data handling and display features of blood ﬂow pat-
terns that allow for analysis of large 3D data sets.
Surprisingly, issues that where perceived as major
obstacles in the not-so-distant past (like for example
turnaround times for the number-crunching aspects of
such models, or the availability of adequately versatile
software for such simulations) seem to recede with the
abundance and low-cost cluster parallel computing
and affordable software suites for computational
hemodynamics.
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The following steps are recommended to promote
the translation to clinical applications in this rapidly
evolving ﬁeld:
 Strengthen bridges between computational
models and physiology and vascular biology
(cell signaling pathways in atherogenesis, rup-
ture risk, remodeling)
 Encourage closer collaboration of basic life sci-
ence and clinical medicine with imaging and bio-
ﬂuid engineers. Enhance communication and
cross-fertilization by publishing bioﬂuid mechan-
icsbooksand/orreviewarticlesinclinicaljournals
addressed to physicians. Host special sessions at
clinical cardiology conferences (AHA/ACC), and
invite clinicians to present keynote lectures at
bioﬂuid/engineering conferences.
 Incorporate basic biomedical engineering cour-
ses in medical curricula and offer training in
physiological/biological modeling to biomedical
engineers
 Maintain and deepen contacts with the medical
device industry.
 Improve imaging (acquisition time, temporal
and spatial resolution) and both anatomical
and bioﬂuid/biophysical feature extraction.
 Incorporate mechanical properties and sur-
rounding structures/forces in CFD. Realistic
parameter estimation (material, physiologic,
biologic) requires an interdisciplinary
approach. Experts from different disciplines
should be brought together by organizing
themed conferences.
 Validation–validation–validation… in vitro and
in vivo.
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